FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013693091> ?p ?o ?g. }

• W2013693091 endingPage "701.e3" @default.
• W2013693091 startingPage "693" @default.
• W2013693091 abstract "We examined the effect of the renin inhibitor, aliskiren, on renal blood flow (RBF) in patients with heart failure with reduced ejection fraction (HFREF) and decreased glomerular filtration rate (GFR). Renal blood flow is the main determinant of GFR in HFREF patients. Both reduced GFR and RBF are associated with increased mortality. Aliskiren can provide additional renin-angiotensin-aldosterone system inhibition and increases RBF in healthy individuals.Patients with left ventricular ejection fraction ≤45% and estimated GFR 30 to 75 mL/min per 1.73 m(2) on optimal medical therapy were randomized 2:1 to receive aliskiren 300 mg once daily or placebo. Renal blood flow and GFR were measured using radioactive-labeled (125)I-iothalamate and (131)I-hippuran at baseline and 26 weeks. After 41 patients were included, the trial was halted based on an interim safety analysis showing futility. Mean age was 68 ± 9 years, 82% male, GFR (49 ± 16 mL/min per 1.73 m(2)), RBF (294 ± 77 mL/min per 1.73 m(2)), and NT-proBNP 999 (435-2040) pg/mL. There was a nonsignificant change in RBF after 26 weeks in the aliskiren group compared with placebo (-7.1 ± 30 vs +14 ± 54 mL/min per 1.73 m(2); P = .16). However, GFR decreased significantly in the aliskiren group compared with placebo (-2.8 ± 6.0 vs +4.4 ± 9.6 mL/min per 1.73 m(2); P = .01) as did filtration fraction (-2.2 ± 3.3 vs +1.1 ± 3.1%; P = .01). There were no significant differences in plasma aldosterone, NT-proBNP, urinary tubular markers, or adverse events. Plasma renin activity was markedly reduced in the aliskiren group versus placebo throughout the treatment phase (P = .007).Adding aliskiren on top of optimal HFREF medical therapy did not improve RBF and was associated with a reduction of GFR and filtration fraction." @default.
• W2013693091 created "2016-06-24" @default.
• W2013693091 creator A5003503629 @default.
• W2013693091 creator A5010367070 @default.
• W2013693091 creator A5033537614 @default.
• W2013693091 creator A5040848501 @default.
• W2013693091 creator A5051270747 @default.
• W2013693091 creator A5061326625 @default.
• W2013693091 creator A5065063426 @default.
• W2013693091 creator A5069496306 @default.
• W2013693091 creator A5074566771 @default.
• W2013693091 date "2015-05-01" @default.
• W2013693091 modified "2023-09-27" @default.
• W2013693091 title "Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction)" @default.
• W2013693091 cites W1417697020 @default.
• W2013693091 cites W1981928687 @default.
• W2013693091 cites W1993104550 @default.
• W2013693091 cites W1994079702 @default.
• W2013693091 cites W1997062534 @default.
• W2013693091 cites W1998528267 @default.
• W2013693091 cites W2006078326 @default.
• W2013693091 cites W2016225716 @default.
• W2013693091 cites W2026881482 @default.
• W2013693091 cites W2039880240 @default.
• W2013693091 cites W2040797094 @default.
• W2013693091 cites W2047801290 @default.
• W2013693091 cites W2048665589 @default.
• W2013693091 cites W2056853966 @default.
• W2013693091 cites W2074330505 @default.
• W2013693091 cites W2078762775 @default.
• W2013693091 cites W2093276210 @default.
• W2013693091 cites W2105564861 @default.
• W2013693091 cites W2122625788 @default.
• W2013693091 cites W2122726836 @default.
• W2013693091 cites W2133174231 @default.
• W2013693091 cites W2137177722 @default.
• W2013693091 cites W2138862624 @default.
• W2013693091 cites W2152334831 @default.
• W2013693091 cites W2168507847 @default.
• W2013693091 cites W2169268865 @default.
• W2013693091 cites W4293085726 @default.
• W2013693091 doi "https://doi.org/10.1016/j.ahj.2014.12.016" @default.
• W2013693091 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25965717" @default.
• W2013693091 hasPublicationYear "2015" @default.
• W2013693091 type Work @default.
• W2013693091 sameAs 2013693091 @default.
• W2013693091 citedByCount "16" @default.
• W2013693091 countsByYear W20136930912016 @default.
• W2013693091 countsByYear W20136930912017 @default.
• W2013693091 countsByYear W20136930912018 @default.
• W2013693091 countsByYear W20136930912019 @default.
• W2013693091 countsByYear W20136930912020 @default.
• W2013693091 countsByYear W20136930912021 @default.
• W2013693091 countsByYear W20136930912022 @default.
• W2013693091 crossrefType "journal-article" @default.
• W2013693091 hasAuthorship W2013693091A5003503629 @default.
• W2013693091 hasAuthorship W2013693091A5010367070 @default.
• W2013693091 hasAuthorship W2013693091A5033537614 @default.
• W2013693091 hasAuthorship W2013693091A5040848501 @default.
• W2013693091 hasAuthorship W2013693091A5051270747 @default.
• W2013693091 hasAuthorship W2013693091A5061326625 @default.
• W2013693091 hasAuthorship W2013693091A5065063426 @default.
• W2013693091 hasAuthorship W2013693091A5069496306 @default.
• W2013693091 hasAuthorship W2013693091A5074566771 @default.
• W2013693091 hasConcept C119584498 @default.
• W2013693091 hasConcept C126322002 @default.
• W2013693091 hasConcept C126894567 @default.
• W2013693091 hasConcept C134018914 @default.
• W2013693091 hasConcept C138976137 @default.
• W2013693091 hasConcept C142225936 @default.
• W2013693091 hasConcept C142724271 @default.
• W2013693091 hasConcept C159641895 @default.
• W2013693091 hasConcept C164705383 @default.
• W2013693091 hasConcept C198710026 @default.
• W2013693091 hasConcept C204787440 @default.
• W2013693091 hasConcept C21652263 @default.
• W2013693091 hasConcept C27081682 @default.
• W2013693091 hasConcept C2777425892 @default.
• W2013693091 hasConcept C2778198053 @default.
• W2013693091 hasConcept C2779838083 @default.
• W2013693091 hasConcept C2780091579 @default.
• W2013693091 hasConcept C71924100 @default.
• W2013693091 hasConcept C78085059 @default.
• W2013693091 hasConcept C84393581 @default.
• W2013693091 hasConceptScore W2013693091C119584498 @default.
• W2013693091 hasConceptScore W2013693091C126322002 @default.
• W2013693091 hasConceptScore W2013693091C126894567 @default.
• W2013693091 hasConceptScore W2013693091C134018914 @default.
• W2013693091 hasConceptScore W2013693091C138976137 @default.
• W2013693091 hasConceptScore W2013693091C142225936 @default.
• W2013693091 hasConceptScore W2013693091C142724271 @default.
• W2013693091 hasConceptScore W2013693091C159641895 @default.
• W2013693091 hasConceptScore W2013693091C164705383 @default.
• W2013693091 hasConceptScore W2013693091C198710026 @default.
• W2013693091 hasConceptScore W2013693091C204787440 @default.
• W2013693091 hasConceptScore W2013693091C21652263 @default.
• W2013693091 hasConceptScore W2013693091C27081682 @default.
• W2013693091 hasConceptScore W2013693091C2777425892 @default.

• next